| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-10 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-08 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |